Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

A small number of patients using GLP-1 weight loss medications have experienced vision loss, although researchers have not ...

Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.

Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with onli ...

From revenue to R&D investment, Novo and Lilly and their mega-blockbuster weight loss drugs Zepbound and Wegovy have moved ...

ANSWER: “Floaters” are bits of cellular debris in the vitreous humor, which is the gel-filled space in between the lens and ...

Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its ...

The eye does not have a way to remove floaters, so you will have them as long as you live unless you do something about it.

I am a 67-year-old male with generally good vision. I have had a few floaters in my eyes over the years, but they have generally been small and have not significantly affected my vision. However, ...

They include semaglutide (Wegovy), liraglutide (Saxenda), and tirzepatide (Zepbound). GLP-1 receptor agonists can increase satiety, reduce appetite, and regulate blood sugar levels — all of ...

Zepbound (tirzepatide) is a prescription injection that comes as a single-dose pen or single-dose vial. If your doctor prescribes Zepbound to you and you need to travel, there are certain things ...

Researchers looked at the nine people who had vision problems while using the drugs and is one of several that have ...